AriVac is a company specializing in the development of products and services to improve animal health and food safety. With its cutting-edge diagnostic tests, pharmaceuticals, and vaccines, AriVac is revolutionizing veterinary care, particularly in the field of rapid diagnostics.
Founded in 2003 by Maamar Achacha, who has always been passionate about veterinary medicine, AriVac has grown from a biotechnology research project to a leader in diagnostic tools.
Since 2013, under Achacha’s leadership, the company has introduced innovations such as "Lab in Box" – a portable diagnostic kit that allows veterinarians to perform accurate tests in the field in just 5 to 10 minutes. This technology enables quick identification of pathogens causing digestive, reproductive, or respiratory issues in animals, allowing for faster treatments and better disease control.
AriVac’s commitment to innovation is also reflected in the development of Altermate, a product for synchronizing estrus in sows, the only one of its kind available in Canada for pork producers. The company continues to adapt its products to respond to emerging animal diseases, with a rapid test currently in development for SRRP, a global disease affecting pigs.
Looking to the future, AriVac aims for international expansion, with plans to grow its product range and enhance the lives of its clients globally. The company also plans to expand its team to become a global leader in veterinary biotechnology.